BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19956844)

  • 1. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.
    Cheng TC; Hsieh SS; Hsu WL; Chen YF; Ho HH; Sheu LF
    Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
    Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
    Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
    Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
    Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line.
    Oh ST; Kim M; Lee SK
    Arch Pharm Res; 2009 May; 32(5):729-36. PubMed ID: 19471888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
    Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
    PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
    Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
    Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells.
    Kim SM; Hur DY; Hong SW; Kim JH
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):550-555. PubMed ID: 29061308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal.
    Chao M; Wang HN; Lu YJ; Chang YS; Yu JS
    Oncol Rep; 2015 Feb; 33(2):958-66. PubMed ID: 25434292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Insight Into p53-Inhibiting Genes in Epstein–Barr Virus-Associated Gastric Adenocarcinoma.
    Hashemi SMA; Moradi A; Hosseini SY; Razavi Nikoo H; Bamdad T; Faghih Z; Sarvari J; Tabarraei A
    Iran Biomed J; 2023 Jan; 27(1):34-45. PubMed ID: 36624687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma.
    Leung SY; Chau KY; Yuen ST; Chu KM; Branicki FJ; Chung LP
    Histopathology; 1998 Oct; 33(4):311-7. PubMed ID: 9822919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
    Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.